In SLE patients, the abnormal metabolism of T cells, including high mTOR activation, increased glutaminolysis, active lipid synthesis, and enhanced glycolysis, all contribute to the differentiation and function of Th17. The gene discussed is MTOR; the disease is systemic lupus erythematosus.